The research team stated, "We have provided direct genetic evidence that variants in the drug's target gene create differences in treatment response." They added, "Using genetic information, we can predict which drug will work best for each patient and what side effects to expect before starting treatment." In a commentary published alongside the study in Nature, Ruth J.F
Future research should aim to validate these findings in diverse patient populations and assess the long-term sustainability of weight loss and associated benefits
it can be taken as a pill or under the tongueis when there is a deficiency that can be caused by pernicious anemia, celiac or Crohns disease, or weight loss procedures such as gastric bypass surgery, which interferes with the bodys ability to extract vitamins from food
Alternate injection sites to minimise sensitivity
In: DeGroot LJ, Jameson JL, editors
Semaglutide and tirzepatide: The medications First, lets take a look at the medications that contain these active ingredients